Drug intelligence / Profile preview

sumatriptan + naproxen sodium

Development stage
Approved
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Sumatriptan + naproxen sodium is a fixed-dose combination oral medication used for the acute treatment of migraine attacks with or without aura in adults and pediatric patients 12 years of age and older. It combines two active ingredients: - Sumatriptan, a selective serotonin (5-HT) 1b/1d receptor agonist (triptan), which works by causing vasoconstriction of cranial blood vessels and inhibiting pro-inflammatory neuropeptide release. - Naproxen sodium, a nonsteroidal anti-inflammatory drug (NSAID) from the arylacetic acid group, which reduces inflammation by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. The combination provides greater initial and sustained pain relief compared to either agent alone. It is not indicated for migraine prevention or cluster headaches[1][3][6][8].

Brand names
TreximetSuvexx
Other names
sumatriptan/naproxensumatriptan and naproxen sodium
02

Targets

HTR1B (5-Hydroxytryptamine Receptor 1B)HTR1D (5-hydroxytryptamine receptor 1D)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on sumatriptan + naproxen sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sumatriptan + naproxen sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call